TRAIL and Cardiovascular Disease—A Risk Factor or Risk Marker: A Systematic Review
Open Access
- 18 March 2021
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (6) , 1252
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a pro-apoptotic protein showing broad biological functions. Data from animal studies indicate that TRAIL may possibly contribute to the pathophysiology of cardiomyopathy, atherosclerosis, ischemic stroke and abdominal aortic aneurysm. It has been also suggested that TRAIL might be useful in cardiovascular risk stratification. This systematic review aimed to evaluate whether TRAIL is a risk factor or risk marker in cardiovascular diseases (CVDs) focusing on major adverse cardiovascular events. Two databases (PubMed and Cochrane Library) were searched until December 2020 without a year limit in accordance to the PRISMA guidelines. A total of 63 eligible original studies were identified and included in our systematic review. Studies suggest an important role of TRAIL in disorders such as heart failure, myocardial infarction, atrial fibrillation, ischemic stroke, peripheral artery disease, and pulmonary and gestational hypertension. Most evidence associates reduced TRAIL levels and increased TRAIL-R2 concentration with all-cause mortality in patients with CVDs. It is, however, unclear whether low TRAIL levels should be considered as a risk factor rather than a risk marker of CVDs. Further studies are needed to better define the association of TRAIL with cardiovascular diseases.Keywords
This publication has 97 references indexed in Scilit:
- Immunological Profile of Silent Brain Infarction and Lacunar StrokePLOS ONE, 2013
- Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome PatientsPLOS ONE, 2013
- Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertensionJournal of Experimental Medicine, 2012
- TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient miceAtherosclerosis, 2011
- Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adultsAtherosclerosis, 2011
- Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T cells in acute coronary syndromeAtherosclerosis, 2010
- Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes MellitusMediators of Inflammation, 2010
- Following TRAIL’s path in the immune systemImmunology, 2009
- Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial InfarctionPLOS ONE, 2009
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005